Mumps

Lore & Background

During the First World War, mumps was a debilitating disease among soldiers. Johnson and Ernest William Goodpasture, who transmitted it to rhesus macaques via saliva from infected humans, proving its viral nature.

Reader's Guide

Mumps historically caused widespread illness, especially in children aged 5–9, with complications including deafness and inflammation of the testes, ovaries, pancreas, and brain. The development of the MMR vaccine in the 1970s led to near-elimination in vaccinating countries, with a 99.9% reduction in U.S. However, in the 21st century, mumps has resurged in many vaccinated populations, primarily among adolescents and young adults in crowded settings. This resurgence is attributed to waning vaccine immunity, low vaccination rates, and opposition to vaccination. The MMR vaccine remains safe and effective, and isolation of infected individuals helps prevent spread.

Did You Know?

• About one-third of infected people have no symptoms (asymptomatic).
• Mumps can cause testicular inflammation, which may lead to reduced fertility and rarely sterility.
• The Jeryl Lynn strain used in Mumpsvax was taken from Maurice Hilleman's five-year-old daughter.

The Virus and Its Pathway

Mumps is caused by an RNA virus belonging to the Paramyxoviridae family, and humans serve as its sole natural host. The virus travels primarily through respiratory droplets and saliva, making crowded settings particularly vulnerable to outbreaks. An infected person can shed the virus from roughly a week before symptoms appear through eight days after they begin. Once inside a new host, the virus first takes hold in the upper respiratory tract before migrating to the salivary glands and lymph nodes. Infection of those lymph nodes releases the virus into the bloodstream, where it can seed the rest of the body. The hallmark sign—painful swelling of the parotid glands on either side of the face—typically emerges 16 to 18 days after exposure, preceded by nonspecific complaints like fever, headache, muscle aches, and poor appetite. Notably, roughly one-third of infected individuals never develop any visible symptoms at all, making silent transmission a persistent challenge for public health surveillance.

From Ancient Records to a Daughter's Saliva

Written references to mumps stretch back to 640 B.C. in Chinese medical texts, and Hippocrates described an outbreak on the island of Thasos around 410 B.C. in his work Epidemics. Yet the actual causative agent remained unknown for millennia. In 1934, researchers Claude D. Johnson and Ernest William Goodpasture demonstrated that the disease was viral by showing rhesus macaques developed mumps after exposure to human saliva, and that the infection could then be passed to children using bacteria-free preparations of monkey parotid tissue. The virus itself was isolated for the first time in 1945. The breakthrough in prevention came through Maurice Hilleman, who in 1967 developed Mumpsvax using the Jeryl Lynn strain—named after his five-year-old daughter, from whom the virus was originally cultured. Hilleman later combined this attenuated mumps vaccine with measles and rubella components, producing the MMR-2 formulation approved by the FDA in 1971. By the 1980s, a two-dose schedule was widely adopted, and countries that embraced vaccination saw case numbers plummet by as much as 97 percent.

When Infection Turns Serious

Although mumps is generally self-limiting and resolves as the immune system clears the virus, complications—while rare—can be severe. Because there is no specific antiviral treatment, management is purely supportive: rest, pain relief, and monitoring. The most commonly cited complications involve inflammation of the testes, ovaries, breasts, pancreas, meninges, and brain. Testicular inflammation carries the particular risk of reduced fertility and, in uncommon cases, sterility. Deafness is another documented but infrequent consequence. Symptoms and complications tend to hit males harder and run more severely in adolescents and adults than in young children. In regions where mumps is endemic, clinicians can often diagnose the disease from its clinical presentation alone. In areas where it is uncommon, however, confirmation requires laboratory work such as antibody testing, viral culture, or real-time reverse transcription polymerase chain reaction. Isolating infected individuals remains a key strategy to halt further spread while the body fights the infection on its own.

The 21st Century Comeback

For decades after widespread MMR adoption, mumps was nearly eradicated in many nations. Finland, for instance, reduced its incidence to fewer than one case per 100,000 people annually, and the United States saw a 97 percent drop in cases between 1968 and 1982. Yet the 21st century has brought an uncomfortable reversal. In numerous countries with established vaccination programs, mumps cases have climbed again, disproportionately affecting adolescents and young adults. Public health experts point to several converging factors: vaccine-induced immunity that wanes over time, and a growing wave of opposition to vaccination that has eroded community-level coverage. The disease's seasonal pattern—peaking in winter and spring in temperate zones, with no clear seasonality in tropical regions—means outbreaks can strike with particular force in dormitories, workplaces, and other densely populated settings. The MMR vaccine, which also guards against measles and rubella, remains the single most effective tool available, but its success now depends on sustaining high uptake across entire populations rather than merely introducing it.

Gallery